Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zic family member 1 (ZIC1) is a C2H2-type zinc finger transcription factor that plays a critical role in neural development, cranial morphogenesis, and organogenesis by regulating the proliferation, differentiation, and regional patterning of neural progenitors[1][2][3][4]. ZIC1 is highly conserved among vertebrates, functions in DNA binding and protein-protein interactions, and acts primarily as a developmental regulator. Loss-of-function or mutation of ZIC1 is associated with congenital disorders such as Dandy–Walker syndrome and craniosynostosis. In cancer, ZIC1 typically functions as a tumor suppressor by inhibiting cell proliferation and promoting apoptosis via regulation of key signaling pathways (MAPK, PI3K/Akt, Wnt/β-catenin), although it may promote oncogenesis in certain mesenchymal tumors. Its function is tightly controlled by both transcriptional and post-transcriptional mechanisms, including mRNA G-quadruplex-mediated translation regulation[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zic family member 1 (ZIC1).